Journals / Journal of Clinical and Experimental Investigations / 2012 / Cilt: 3 - Sayı: 1

Total antioksidan kapasite ile koroner arter hastalığı şiddeti arasındaki ilişki

Relationship between total antioxidant capacity and the severity of coronary artery disease

Pages
22–28
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

J Clin Exp Invest 2012; 3(1): 22-28

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: It was known that oxidative/antioxidative balance shifted to oxidative side in patients with coronary artery disease.
📊
Key Findings & Data:Materials and methods: The study group consisted of 87 consecutive patients who were hospitalized for coronary angiography.
💡
Conclusion & Impact:J Clin Exp Invest 2012; 3(1): 22-28
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: It was known that oxidative/antioxidative balance shifted to oxidative side in patients with coronary artery disease. The aim of this study is to evaluate the relationship between coronary artery disease and total antioxidant status, oxidative stress index. Materials and methods: The study group consisted of 87 consecutive patients who were hospitalized for coronary angiography. Plasma total oxidative status (TOS) and total antioxidative capacity (TAC) levels were measured and oxidative stress index (OSI) was calculated. Results: The TAC values increased statistically significant in the four tertile compared with the first tertile (1.9 ± 0.2 vs 2.0 ± 0.2 mmol Trolox Eq/l) and the TOS values decreased non- significantly in the four tertile ( 5.2 ± 2.8 vs 7.2 ± 5.4 μmol H2O2 Eq/l) as compared to the patients in the first tertile. According to the number of diseased vessels, plasma oxidative characteristics did not differ between the three groups. Conclusions: Plasma TAC levels increased in subjects with coronary atherosclerosis and severity of coronary atherosclerosis is related with TAC. J Clin Exp Invest 2012; 3(1): 22-28

Özet

Amaç: Koroner arter hastalarında oksidatif/ antioksidatif dengenin oksidatif taraf lehine kaydığı bilinmektedir. Bu çalışmanın amacı, total antioksidan durum, oksidatif yük ve koroner arter hastalığı arasındaki ilişkiyi incelemektir. Gereç ve yöntem: Çalışma grubu, koroner Anjiyografi yapmak için hastaneye yatırılan ardışık 87 hastadan oluşmaktadır. Plazma total oksidatif durum (TOD) ve total antioksidan kapasite (TAK) seviyeleri ölçüldü ve oksidatif stres indeksi (OSİ) hesaplandı. Bulgular: Dördüncü gruptaki TAK değerleri ilk grup (1.9 ± 0.2 vs 2.0 ± 0.2 mmol Trolox Eq/l) ile karşılaştırıldığında istatistiksel olarak anlamlı derecede artmıştı ve birinci gruptaki hastalar ile karşılaştırıldığında, dördüncü gruptaki ( 5.2 ± 2.8 vs 7.2 ± 5.4 μmol H2O2 Eq/l) TOD değerlerindeki azalma anlamlı değildi. Hastalıklı damar sayısına göre, plazma oksidatif özellikleri üç grup arasında farklı bulunmadı. Sonuç: Plazma TAK düzeyleri koroner arter hastalığı olan kişilerde artmıştır ve koroner aterosklerozun ağırlığı TAK ile ilişkilidir.

🔖

Cite This Article

YALÇIN, K. S., NAZLI, Y., SELCOKI, Y., YİĞİTOĞLU, R., DEMİRÇELİK, B., ÇOLAK, N., ERYONUCU, B., AYDIN, M., CANBAL, M. (2022). Total antioksidan kapasite ile koroner arter hastalığı şiddeti arasındaki ilişki. Journal of Clinical and Experimental Investigations, Cilt: 3 - Sayı: 1, 22–28. https://ajindex.com/articles/561972

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India 2004; 52(1): 94-9
  2. Serdar Z, Aslan K, Dirican M, Sarandöl E, Yesilbursa D, Serdar A. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clin Biochem 2006; 39(8):794- 803
  3. Bridges BA, Bowyer DE, Hansen ES, Penn A, Wakabayashi K. The possible involvement of somatic mutations in the development of atherosclerotic plaques. Mutat Res 1990;239 (3):143-8
  4. Nojiri S. Daida H, Mokuno H, et al. Association of serum antioxidant capacity with coronary artery disease in middle-aged men. Jpn Heart J 2001; 42 (6):677-90
  5. Schwenke DC. Antioxidants and atherogenesis. J Nutr Biochem 1998;9: 424-45
  6. Yeum KJ, Russell RM, Krinsky NI, Aldini G. Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma. Arch Biochem Biophys 2004;430 (1):97-103
  7. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37(2):112-9
  8. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38(12):1103-11
  9. Gur M, Aslan M, Yildiz A, et al. Paraoxonase and arylesterase activities in coronary artery disease. Eur J Clin Invest 2006; 36(11):779-87
  10. Demirbag R, Yilmaz R, Kocyigit A. Relationship between DNA damage, total antioxidant capacity and coronary artery disease. Mutat Res 2005; 570(2):197- 203
  11. Austen WG, Edwards JE, Frye RL, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975;51(4 Suppl):5-40
  12. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51(3):606-7
  13. Demirbag R, Gur M, Yilmaz R, Kunt AS, Erel O, Andac MH. Influence of oxidative stress on the development of collateral circulation in total coronary occlusions. Int J Cardiol 2007;116(1):14-9
  14. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001;54(3): 176-86
  15. Lopes HF, Martin KL, Nashar K, Morrow JD, Goodfriend TL, Egan BM. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension 2003;41(3):422-30
  16. Casal